Justin Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Justin Lee has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Ian Poon
Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
3 shared publications - Irene Karam
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada
3 shared publications - Kevin M. Higgins
University of Toronto
3 shared publications - Martin Joel Yaffe
Biomarker Imaging Research Lab (BIRL), Sunnybrook Research Institute, Toronto, Canada
3 shared publications Maureen Trudeau
3 shared publications- Ali Sadeghi-Naini
Department of Electrical Engineering and Computer Science, Lassonde School of Engineering, York University, Toronto, Canada
2 shared publications
Latest Publications
- Open Access
- 1 September 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 120, S8
21: Can Intratreatment Pet CT-Based Adaptive Radiotherapy Reduce Treatment Margins in Head and Neck Cancers?
- 1 September 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 120, S8
Open Access21: Can Intratreatment Pet CT-Based Adaptive Radiotherapy Reduce Treatment Margins in Head and Neck Cancers?
- Open Access
- 1 September 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 120, S75-S76
207: Treatment of Unresected Locally Advanced Breast Cancer with Hypofractionated Partial Breast Irradiation: Clinical Outcomes and Feasibility
- 1 September 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 120, S75-S76
Open Access207: Treatment of Unresected Locally Advanced Breast Cancer with Hypofractionated Partial Breast Irradiation: Clinical Outcomes and Feasibility
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 6044
Readmission and emergency department visits in the peri-treatment period for head and neck cancers patients in Ontario.
6044 Background: Mucosal head and neck squamous cell cancers are often managed with multimodality treatment which can be associated with significant toxicity. The objective of this study was to assess emergency department visits and non-elective hospitalizations for head and neck cancer patients during and immediately after their treatment. Methods: A cohort of patients treated for head and neck squamous cell carcinoma with curative intent was developed using administrative data. Emergency department visits and hospitalizations in the peri-treatment 90 day period following surgery, radiation, or chemoradiathion was determined. If a second treatment was initiated prior to the completion of 90 days, the attributable risk period was changed to the second treatment. Results: Cohort of 3,920 patients (1,317 larynx/hypopharynx; 2,603 oral cavity/oropharynx) from 2008-2012. The number of non-elective hospitalizations (per 100 patient days) attributable to surgery, radiation and chemoradiation was 0.35, 0.13, and 0.3 for larynx/hypopharynx and 0.11, 0.17, and 0.23 for oral cavity/oropharynx respectively. The number of emergency department visits (per 100 patient days) attributable to surgery, radiation and chemoradiation was 0.89, 0.34, and 0.7 for larynx/hypopharynx and 0.44, 0.36, and 0.55 for oral cavity/oropharynx respectively. Multimodality treatment rendered higher readmission and emergency department visits. Conclusions: Patients undergoing treatment for head and neck cancer have significant non-elective hospitalizations and visits to the emergency department in the peri-treatment period. Rates are higher in patients receiving multi-modality treatment, specifically, patients receiving chemoradiation have much higher non-elective hospitalizations and visits to the emergency department compared to those receiving radiotherapy alone or surgery alone. Further research is required to determine predictors of these outcomes and to identify high risk groups for which quality improvement interventions can be focused.
- 20 May 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (15_suppl) , 6044
Readmission and emergency department visits in the peri-treatment period for head and neck cancers patients in Ontario.
6044 Background: Mucosal head and neck squamous cell cancers are often managed with multimodality treatment which can be associated with significant toxicity. The objective of this study was to assess emergency department visits and non-elective hospitalizations for head and neck cancer patients during and immediately after their treatment. Methods: A cohort of patients treated for head and neck squamous cell carcinoma with curative intent was developed using administrative data. Emergency department visits and hospitalizations in the peri-treatment 90 day period following surgery, radiation, or chemoradiathion was determined. If a second treatment was initiated prior to the completion of 90 days, the attributable risk period was changed to the second treatment. Results: Cohort of 3,920 patients (1,317 larynx/hypopharynx; 2,603 oral cavity/oropharynx) from 2008-2012. The number of non-elective hospitalizations (per 100 patient days) attributable to surgery, radiation and chemoradiation was 0.35, 0.13, and 0.3 for larynx/hypopharynx and 0.11, 0.17, and 0.23 for oral cavity/oropharynx respectively. The number of emergency department visits (per 100 patient days) attributable to surgery, radiation and chemoradiation was 0.89, 0.34, and 0.7 for larynx/hypopharynx and 0.44, 0.36, and 0.55 for oral cavity/oropharynx respectively. Multimodality treatment rendered higher readmission and emergency department visits. Conclusions: Patients undergoing treatment for head and neck cancer have significant non-elective hospitalizations and visits to the emergency department in the peri-treatment period. Rates are higher in patients receiving multi-modality treatment, specifically, patients receiving chemoradiation have much higher non-elective hospitalizations and visits to the emergency department compared to those receiving radiotherapy alone or surgery alone. Further research is required to determine predictors of these outcomes and to identify high risk groups for which quality improvement interventions can be focused.
- Open Access
- 2 April 2016
- Published by Springer Nature in Journal of Therapeutic Ultrasound
- Vol. 4 (1) , 1-7
Magnetic resonance-guided high-intensity focused ultrasound combined with radiotherapy for palliation of head and neck cancer—a pilot study
Radiotherapy is a critical component of the multidisciplinary management of cancers of the head and neck. It may comprise the primary curative treatment modality or is used in an adjuvant setting to improve local control and survival by preventing seeding and reseeding of distant metastases from persistent reservoirs of locoregional disease. Although considerable advances have been made recently in the fields of radiotherapy, systemic treatment and surgery for head and neck tumours, locoregional recurrence rates remain high and treatment side effects may have severe impact on patients’ quality of life. Magnetic resonance-guided high-intensity focused ultrasound (MRg-HIFU) is a novel technique in the treatment of cancer that has the potential to improve tumour cure rates and decrease treatment-related toxicity. Clinical applications of HIFU are being used increasingly for the treatment of several tumour sites, for example uterine leiomyomas and prostate cancer. The pilot study presented here is an initial step toward utilizing MRg-HIFU for head and neck cancer treatment. The rationale for novel treatment options in head and neck cancer is reviewed as well as emerging evidence that support the increasing clinical utilization of MRg-HIFU. This pilot study aims to assess safety, toxicity and feasibility of MRg-HIFU treatments to the head and neck region and to evaluate changes caused by MRg-HIFU within the treated tumour regions based on post-treatment MRI.
- 2 April 2016
- Published by Springer Nature in Journal of Therapeutic Ultrasound
- Vol. 4 (1) , 1-7
Open AccessMagnetic resonance-guided high-intensity focused ultrasound combined with radiotherapy for palliation of head and neck cancer—a pilot study
Radiotherapy is a critical component of the multidisciplinary management of cancers of the head and neck. It may comprise the primary curative treatment modality or is used in an adjuvant setting to improve local control and survival by preventing seeding and reseeding of distant metastases from persistent reservoirs of locoregional disease. Although considerable advances have been made recently in the fields of radiotherapy, systemic treatment and surgery for head and neck tumours, locoregional recurrence rates remain high and treatment side effects may have severe impact on patients’ quality of life. Magnetic resonance-guided high-intensity focused ultrasound (MRg-HIFU) is a novel technique in the treatment of cancer that has the potential to improve tumour cure rates and decrease treatment-related toxicity. Clinical applications of HIFU are being used increasingly for the treatment of several tumour sites, for example uterine leiomyomas and prostate cancer. The pilot study presented here is an initial step toward utilizing MRg-HIFU for head and neck cancer treatment. The rationale for novel treatment options in head and neck cancer is reviewed as well as emerging evidence that support the increasing clinical utilization of MRg-HIFU. This pilot study aims to assess safety, toxicity and feasibility of MRg-HIFU treatments to the head and neck region and to evaluate changes caused by MRg-HIFU within the treated tumour regions based on post-treatment MRI.
- Open Access
- 1 January 2016
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 45 (1) , 1-17
Comparison of survival between radiation therapy and trans-oral laser microsurgery for early glottic cancer patients; a retrospective cohort study
Background: The literature reports various treatment methodologies, such as trans-oral laser microsurgery, radiation therapy, total/partial laryngectomies, and concurrent radiation chemotherapy for patients with early larynx cancer. However, at the forefront of early glottis treatment is trans-oral laser microsurgery and radiation therapy, likely due to better functional and survival outcomes. Here we conduct the largest Canadian head-to-head comparison of consecutive patients treated with either radiation therapy or trans-oral laser microsurgery. Additionally, we compare these two treatments and their 5-year survival rates post treatment to add to the existing literature. Methods: Charts of patients who were diagnosed with early glottic cancer between 2006 and 2013 were reviewed. Seventy-five patients were identified, and split into 2 groups based on their primary treatment, trans-oral laser microsurgery and radiation therapy. Kaplan–Meier survival curves, life-tables, and the log-rank statistic were reported to determine if there was a difference between the two treatment groups and their disease-specific survival, disease-free survival, and total laryngectomy-free survival. Additionally, each different survival analysis was stratified by potential confounding variables, to help conclude which treatment is more efficacious in this population. Results: The 5-year disease-specific survival rate is 93.3 % σ = 0.063 and 90.8 % σ = 0.056 for patients treated with trans-oral laser microsurgery and radiation therapy, respectively ( χ2 < 0.001, p = 0.983). The disease free survival rate is 60.0 % (σ =0.121) for patients treated with trans-oral laser microsurgery, and 67.2 % (σ = 0.074) for those who received RT ( χ2 = 0.19, p = 0.663). Additionally, the total laryngectomy-free survival rate is 84.1 % (σ = 0.1) and 79.1 % (σ = 0.072) for patients’ early glottic cancer treated by trans-oral laser microsurgery and radiation therapy, respectively ( χ2 = 0.235, p = 0.628). Chi-square analysis of age-group versus treatment group ( χ2 = 6.455, p = 0.04) and T-stage versus treatment group ( χ2 = 11.3, p = 0.001) revealed a statistically significant relationship, suggesting survival analysis should be stratified by these variables. However, after stratification, there was no statistically significant difference between the trans-oral laser microsurgery and radiation therapy groups in any of the survival analyses. Conclusion: No difference was demonstrated in the 5-year disease-specific survival, disease-free survival, and total laryngectomy-free survival, between the RT and TLM treatment groups. Additionally, both groups showed similar 5-year survival after stratifying by confounding variables.
- 1 January 2016
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 45 (1) , 1-17
Open AccessComparison of survival between radiation therapy and trans-oral laser microsurgery for early glottic cancer patients; a retrospective cohort study
Background: The literature reports various treatment methodologies, such as trans-oral laser microsurgery, radiation therapy, total/partial laryngectomies, and concurrent radiation chemotherapy for patients with early larynx cancer. However, at the forefront of early glottis treatment is trans-oral laser microsurgery and radiation therapy, likely due to better functional and survival outcomes. Here we conduct the largest Canadian head-to-head comparison of consecutive patients treated with either radiation therapy or trans-oral laser microsurgery. Additionally, we compare these two treatments and their 5-year survival rates post treatment to add to the existing literature. Methods: Charts of patients who were diagnosed with early glottic cancer between 2006 and 2013 were reviewed. Seventy-five patients were identified, and split into 2 groups based on their primary treatment, trans-oral laser microsurgery and radiation therapy. Kaplan–Meier survival curves, life-tables, and the log-rank statistic were reported to determine if there was a difference between the two treatment groups and their disease-specific survival, disease-free survival, and total laryngectomy-free survival. Additionally, each different survival analysis was stratified by potential confounding variables, to help conclude which treatment is more efficacious in this population. Results: The 5-year disease-specific survival rate is 93.3 % σ = 0.063 and 90.8 % σ = 0.056 for patients treated with trans-oral laser microsurgery and radiation therapy, respectively ( χ2 < 0.001, p = 0.983). The disease free survival rate is 60.0 % (σ =0.121) for patients treated with trans-oral laser microsurgery, and 67.2 % (σ = 0.074) for those who received RT ( χ2 = 0.19, p = 0.663). Additionally, the total laryngectomy-free survival rate is 84.1 % (σ = 0.1) and 79.1 % (σ = 0.072) for patients’ early glottic cancer treated by trans-oral laser microsurgery and radiation therapy, respectively ( χ2 = 0.235, p = 0.628). Chi-square analysis of age-group versus treatment group ( χ2 = 6.455, p = 0.04) and T-stage versus treatment group ( χ2 = 11.3, p = 0.001) revealed a statistically significant relationship, suggesting survival analysis should be stratified by these variables. However, after stratification, there was no statistically significant difference between the trans-oral laser microsurgery and radiation therapy groups in any of the survival analyses. Conclusion: No difference was demonstrated in the 5-year disease-specific survival, disease-free survival, and total laryngectomy-free survival, between the RT and TLM treatment groups. Additionally, both groups showed similar 5-year survival after stratifying by confounding variables.
- 1 January 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 118 (1) , 187-193
A dosimetric study of cardiac dose sparing using the reverse semi-decubitus technique for left breast and internal mammary chain irradiation
- 1 January 2016
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 118 (1) , 187-193
A dosimetric study of cardiac dose sparing using the reverse semi-decubitus technique for left breast and internal mammary chain irradiation
- 1 May 2015
- Published by Elsevier in Pathology - Research and Practice
- Vol. 211 (5) , 398-403
Tumor shrinkage associated with whole-mount histopathologic techniques in oral tongue carcinoma
- 1 May 2015
- Published by Elsevier in Pathology - Research and Practice
- Vol. 211 (5) , 398-403
Tumor shrinkage associated with whole-mount histopathologic techniques in oral tongue carcinoma
- Open Access
- 24 December 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 298
Image-guided radiation therapy using surgical clips for localization of colonic metastasis from thyroid cancer.
- 24 December 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 298
Open AccessImage-guided radiation therapy using surgical clips for localization of colonic metastasis from thyroid cancer.